Ultrasmall glutathione-protected gold nanoclusters as next generation radiotherapy sensitizers with high tumor uptake and high renal clearance

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Xiao Dong ^a   Luo, Zhentao ^b   Chen, Jie ^a   Song, Shasha ^a   Yuan, Xun ^b   Shen, Xiu ^a   Wang, Hao ^a   Sun, Yuanming ^a   Gao, Kai ^c   Zhang, Lianfeng ^c   Fan, Saijun ^a   Leong, David Tai ^b   Guo, Meili ^d   Xie, Jianping ^b  

^a INSTITUTE OF RADIATION MEDICINE   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^d TIANJIN CHENGJIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; GOLD; METAL NANOPARTICLE; RADIOSENSITIZING AGENT;

ANIMAL; ANTIBODY SPECIFICITY; BAGG ALBINO MOUSE; BLOOD; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECTS; HYDRODYNAMICS; KIDNEY; MALE; METABOLISM; NEOPLASM; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; THREE DIMENSIONAL IMAGING; TIME; TUMOR VOLUME; ULTRASTRUCTURE; ULTRAVIOLET SPECTROPHOTOMETRY;

ANIMALS; GLUTATHIONE; GOLD; HYDRODYNAMICS; IMAGING, THREE-DIMENSIONAL; KIDNEY; MALE; METAL NANOPARTICLES; MICE, INBRED BALB C; NEOPLASMS; ORGAN SPECIFICITY; RADIATION-SENSITIZING AGENTS; SPECTROPHOTOMETRY, ULTRAVIOLET; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 84923864133     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08669     Document Type: Article

References (58)

1. Jemal, A. et al. Global cancer statistics. CA-Cancer J. Clin. 61, 69-90 (2011).
2. Brown, J. M. & Workman, P. Partition Coefficient as a guide to the development of radiosensitizers which are less toxic than misonidazole. Radiat. Res. 82, 171-190 (1980).
3. Wardman, P. Chemical radiosensitizers for use in radiotherapy. Clin. Oncol. 19, 397-417 (2007).
4. Jain, S. et al. Cell-specific radiosensitization by gold nanoparticles at megavoltage radiation energies. Int. J. Radiat. Oncol. Biol. Phys. 79, 531-539 (2011).
5. Yasui, H. et al. Radiosensitization of tumor cells through endoplasmic reticulum stress induced by PEGylated nanogel containing gold nanoparticles. Cancer lett. 347, 151-158 (2014).
6. Kasid, U. & Dritschilo, A. RAF antisense oligonucleotide as a tumor radiosensitizer. Oncogene 22, 5876-5884 (2003).
7. Kvols, L. K. Radiation Sensitizers: A selective review of molecules targeting DNA and non-DNA targets. J. Nucl. Med. 46, 187S-190S (2005).
8. Heidelberger, C. et al. Studies on fluorinated pyrimidines: II. effects on transplanted tumors. Cancer Res. 18, 305-317 (1958).
9. Herskovic, A. et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. New. Engl. J. Med. 326, 1593-1598 (1992).
10. Robson, M. et al. Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy. Gynecol. Oncol. 89, 281-287 (2003).
11. Aapro, M. S., Martin, C. & Hatty, S. Gemcitabine - a safety review. Anti-Cancer Drugs 9, 191-202 (1998).
12. Legha, S. S. & Dimery, I. W. High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity. J. Clin. Oncol. 3, 1373-1378 (1985).
13. Bokemeyer, C. et al. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br. J. Cancer 77, 1355-1362 (1998).
14. Carozzi, V. et al. Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity. Eur. J. Cancer 45, 656-665 (2009).
15. Ali, H. & van Lier, J. E. Metal complexes as photo- and radiosensitizers. Chem. Rev. 99, 2379-2450 (1999).
16. Butterworth, K. T., McMahon, S. J., Currell, F. J. & Prise, K. M. Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale 4, 4830-4838 (2012).
17. Huang, X., El-Sayed, I. H., Qian, W. & El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128, 2115-2120 (2006).
18. Hainfeld, J. F., Slatkin, D. N. & Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, N309 (2004).
19. Chithrani, D. B. et al. Gold nanoparticles as radiation sensitizers in cancer therapy. Radiat. Res. 173, 719-728 (2010).
20. Rahman, W. N. et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomed-Nanotechnol. 5, 136-142 (2009).
21. Roa, W. et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology 20, 375101 (2009).
22. Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N. & Smilowitz, H. M. Radiotherapy enhancement with gold nanoparticles. J. Pharm. Pharmacol. 60, 977-985 (2008).
23. Lechtman, E. et al. Implications on clinical scenario of gold nanoparticle radiosensitization in regards to photon energy, nanoparticle size, concentration and location. Phys. Med. Biol. 56, 4631 (2011).
24. McMahon, S. J. et al . Biological consequences of nanoscale energy deposition near irradiated heavy atom nanoparticles. Sci. Rep. 1, 1-9 (2011).
25. McMahon, S. J., Mendenhall, M. H., Jain, S. & Currell, F. Radiotherapy in the presence of contrast agents: a general figure of merit and its application to gold nanoparticles. Phys. Med. Biol. 53, 5635 (2008).
26. Zhang, G. et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. Biomaterials 30, 1928-1936 (2009).
27. von Maltzahn, G. et al. Computationally guided photothermal tumor therapy using long-circulating gold nanorod antennas. Cancer Res. 69, 3892-3900 (2009).
28. Huo, S. et al. Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Res. 73, 319-330 (2013).
29. Huang, X. et al. A reexamination of active and rassive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4, 5887-5896 (2010).
30. Chou, L. Y. T. & Chan, W. C. W. Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models. Adv. Healthcare Mater. 1, 714-721 (2012).
31. Choi, C. H. J., Alabi, C. A., Webster, P. & Davis, M. E. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl. Acad. Sci. U.S.A. 107, 1235-1240 (2010).
32. Ma, X. et al. Gold nanoparticles induce autophagosome accumulation through size-dependent nanoparticle uptake and lysosome impairment. ACS Nano 5, 8629-8639 (2011).
33. Zhang, X. D. et al. Ultrasmall Au10-12 (SG)10-12 nanomolecules for high tumor specificity and cancer radiotherapy. Adv. Mater. 26, 4565-4568 (2014).
34. Choi, H. S. et al. Renal clearance of quantum dots. Nat. Biotech. 25, 1165-1170 (2007).
35. Setyawati, M. et al. Titanium dioxide nanomaterials cause endothelial cell leakiness by disrupting the homophilic interaction of VE-cadherin. Nat. Commun. 4, 1673 (2013).
36. Tay, C. Y. et al. Nanoparticles strengthen intracellular tension and retard cellular migration. Nano lett. 14, 83-88 (2013).
37. Zhang, X.-D. et al. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy. Biomaterials 33, 6408-6419 (2012).
38. Lundqvist, M. et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U.S.A. 23, 14265-14270 (2008).
39. Luo, Z., Zheng, K. & Xie, J. Engineering ultrasmall water-soluble gold and silver nanoclusters for biomedical applications. Chem. Commun. 50, 5143-5155 (2014).
40. Luo, Z. et al. From aggregation-induced emission of Au(I)-thiolate complexes to ultrabright Au(0)@Au(I)-thiolate core-shell nanoclusters. J. Am. Chem. Soc. 134, 16662-16670 (2012).
41. Yu, Y. et al. Identification of a highly luminescent Au22(SG)18 nanocluster. J. Am. Chem. Soc. 136, 1246-1249 (2014).
42. Luo, Z. et al. Toward understanding the growth mechanism: tracing all stable intermediate species from reduction of Au (I)-thiolate complexes to evolution of Au 25 nanoclusters. J. Am. Chem. Soc. 136, 10577-10580 (2014).
43. 25 nanoclusters with atomic precision. Angew. Chem. Int. Ed. 53, 4623-4627 (2014).
44. Jin, R. Quantum sized, thiolate-protected gold nanoclusters. Nanoscale 2, 343-362 (2010).
45. Dou, X. et al. Lighting up thiolated Au@Ag nanoclusters via aggregation-induced emission. Nanoscale 6, 157-161 (2014).
46. Zhang, X.-D. et al. Enhanced tumor accumulation of sub-2 nm gold nanoclusters for cancer radiation therapy. Adv. Healthcare Mater. 3, 133-141 (2014).
47. Liu, J. et al. Passive tumor targeting of renal-clearable luminescent gold nanoparticles: long tumor retention and fast normal tissue clearance. J. Am. Chem. Soc. 135, 4978-4981 (2013).
48. Zhou, C., Long, M., Qin, Y., Sun, X. & Zheng, J. Luminescent gold nanoparticles with efficient renal clearance. Angew. Chem. Int. Ed. 50, 3168-3172 (2011).
49. Zhang, X.-D. et al. In vivo renal clearance, biodistribution, toxicity of gold nanoclusters. Biomaterials 33, 4628-4638 (2012).
50. Liu, Z. et al. In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nat. Nanotechnol. 2, 47-52 (2007).
51. Yang, K. et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano letters 10, 3318-3323 (2010).
52. Tay, C. Y., Setyawati, M. I., Xie, J., Parak, W. J. & Leong, D. T. Back to basics: exploiting the innate physico-chemical characteristics of nanomaterials for biomedical applications. Adv. Funct. Mater. 24, 5936-5955 (2014).
53. VinluanIII, R. D. et al. Glutathione-coated luminescent gold nanoparticles: a surface ligand for minimizing serum protein adsorption. ACS Appl. Mater. Inter. 6, 11829-11833 (2014).
54. Zhang, X.-D. et al. Toxicologic effects of gold nanoparticles in vivo by different administration routes. Int. J. Nanomed. 5, 771-781 (2010).
55. Zhang, X.-D. et al. Size-dependent in vivo toxicity of PEG-coated gold nanoparticles. Int. J. Nanomed. 6, 2071-2081 (2011).
56. Chen, J. et al . Sex differences in the toxicity of polyethylene glycol-coated gold nanoparticles in mice. Int. J. Nanomed. 8, 2409-2419 (2013).
57. Pinzani, V. et al . Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review. Cancer Chemother. Pharmacol. 35, 1-9 (1994).
58. Yu, Y., Luo, Z., Yu, Y., Lee, J. Y. & Xie, J. Observation of cluster size growth in CO-directed synthesis of Au25(SR)18 nanoclusters. ACS Nano 6, 7920-7927 (2012).